Bio Protocol vs Turtle — how do they compare? Bio Protocol trades at Rp433.2 (market cap Rp985,65M, Rp169,32M 24h volume), while Turtle trades at Rp764.16 (market cap Rp118,21M, Rp17,7M 24h volume). The key difference: Bio Protocol is far larger — about 8.3× Turtle's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 154,7M / 1B TURTLE (16%) for Turtle. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 17 Days and Turtle for 12 Days on average.
| BIO | TURTLE | |
|---|---|---|
Market Cap | Rp985,65M | Rp118,21M |
Volume (24h) | Rp169,32M | Rp17,7M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 154,7M / 1B TURTLE (16%) |
Typical Hold Time | 17 Days | 12 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp424.33 with a market cap of Rp965.85M, showing neutral technical signals amid bearish moving averages. The token's circulating supply of 2.3M out of 3.3M max indicates 69% circulation with an average hold time of 17 days. Recent technical indicators show mixed signals with RSI in neutral territory while ADX suggests some buying momentum. Support and resistance levels are well-defined between Rp398 and Rp500.
Overall outlook remains neutral with key opportunities in protocol adoption growth, though risks include limited liquidity and typical crypto volatility. Investors should monitor network activity closely as the token operates in a competitive blockchain ecosystem without major recent protocol updates.
TURTLE is trading at Rp771.66 with a market cap of Rp119.21 million, showing bullish technical signals from moving averages and ADX indicators. The token has a limited max supply of 1 million, with 16% in circulation. Current price is near pivot point resistance at Rp797, with support at Rp761.
Overall outlook is cautiously optimistic due to strong technical momentum, but major risks include low liquidity, high volatility from small market cap, and lack of recent ecosystem developments. Investors should monitor for breakout above Rp797 resistance.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Turtle aligns incentives between protocols and liquidity providers to surface unique yield opportunities. Its non-custodial system integrates with APIs and audited smart contracts to track liquidity flows and distribute rewards transparently. Turtle also offers advisory services for protocols seeking efficient liquidity incentives.
Read more on TURTLE →